{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T04:17:25Z","timestamp":1783829845284,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pnpbp.2007.10.016","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T14:55:16Z","timestamp":1196780116000},"page":"552-559","source":"Crossref","is-referenced-by-count":40,"title":["Placebo and modafinil effect on sleepiness in obstructive sleep apnea"],"prefix":"10.1016","volume":"32","author":[{"given":"Lia Rita A.","family":"Bittencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia M.","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e9rio A.","family":"Garbuio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana O.","family":"Palombini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Guilleminault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.10.016_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/22.5.667","article-title":"Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research","volume":"22","author":"American Academy of Sleep Medicine","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib2","first-page":"174","article-title":"Atlas Task Force \u2014 EEG arousals: scoring rules and examples","volume":"15","author":"American Sleep Disorders Association","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib3","first-page":"749","article-title":"Atlas Task Force \u2014 recording and scoring leg movements","volume":"16","author":"American Sleep Disorders Association","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000196661","article-title":"Modafinil in obstructive sleep apnea\u2013hypopnea syndrome: a pilot study in 6 patients","volume":"64","author":"Arnulf","year":"1997","journal-title":"Respiration"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","article-title":"Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome","volume":"18","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.56.6.794","article-title":"Modafinil for excessive daytime sleepiness in myotonic dystrophy","volume":"56","author":"Damian","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1389-9457(03)00108-4","article-title":"Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP","volume":"4","author":"Dinges","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1532-5415.2006.00924.x","article-title":"Clinical characteristics of obstructive sleep apnea in community-dwelling older adults","volume":"54","author":"Endeshaw","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(96)13212-2","article-title":"The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor","volume":"220","author":"Ferraro","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(96)00182-3","article-title":"The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism","volume":"306","author":"Ferraro","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","article-title":"The vigilance promoting drug modafinil increased extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade","volume":"20","author":"Ferraro","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib13","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0028-3908(00)00019-8","article-title":"Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil","volume":"39","author":"Ferraro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/sleep\/19.suppl_9.S117","article-title":"Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment)","volume":"19","author":"Guilleminault","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1468-1331.2000.00087.x","article-title":"Problems associated with switch to modafinil \u2014 a novel alerting agent in narcolepsy","volume":"7","author":"Guilleminault","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib16","first-page":"773","volume":"vol. 165","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib17","first-page":"1418","article-title":"Evidence-based medicine and sleep apnea","volume":"46","author":"Heitman","year":"2001","journal-title":"Respir Care"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0009-9236(99)70112-8","article-title":"Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea?","volume":"65","author":"Heitmann","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","article-title":"Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy","volume":"23","author":"Jasinski","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib22","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(98)10532-9","article-title":"Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial","volume":"19","author":"Jenkinson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib24","first-page":"1291","article-title":"Nasal CPAP therapy in obstructive sleep apnea syndrome: patient compliance","volume":"130","author":"Karrer","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1183\/09031936.02.00404502","article-title":"Public Health and medicolegal implications of sleep apnoea","volume":"20","author":"Krieger","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/sleep\/19.8.626","article-title":"Modafinil decreases hypersomnolence in the English bulldog, a natural animal model of sleep-disordered breathing","volume":"19","author":"Panckeri","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jrn.2004.10.006","article-title":"Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients","volume":"15","author":"Rammohan","year":"2005","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib31","series-title":"A manual of standardized technology, techniques and scoring system for sleep stages of human subjects","author":"Rechtschaffen","year":"1968"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1378\/chest.101.4.898","article-title":"Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders","volume":"101","author":"Sangal","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib34","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib35","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1378\/chest.124.6.2192","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study","volume":"124","author":"Schwartz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0960-8966(03)00030-0","article-title":"Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy","volume":"13","author":"Talbot","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2007.10.016_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea: a population health perpective","volume":"165","author":"Young","year":"2002","journal-title":"AM J Respir Crit Care Med"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T14:23:00Z","timestamp":1557066180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607003855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0278584607003855"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.10.016","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}